endovascular.es

Título: Lombard Medical, Inc. Prices U.S. Initial Public Offering; Raises $55 Million on NASDAQ Global Market Listing
Fecha: 24-04-2014
Irvine, CA April 24, 2014 – Lombard Medical, Inc. announced today the pricing of the initial public
offering of 5,000,000 ordinary shares at a price to the public of $11 per share. The shares will be listed
on the NASDAQ Global Market under the ticker symbol “EVAR” on April 25, 2014. In addition,
Lombard Medical, Inc. has granted the underwriters a 30-day option to purchase up to an additional
750,000 ordinary shares from Lombard Medical, Inc.

In advance of Lombard Medical, Inc.'s shares commencing trading on the NASDAQ Global Market,
trading in the shares of Lombard Medical Technologies PLC on the AIM market of the London Stock
Exchange will be suspended and trading in the shares will be cancelled.

Jefferies LLC and Barclays Capital Inc. are acting as joint book-running managers for the proposed
offering, and BTIG, LLC is acting as co-manager.

A registration statement relating to these securities has been filed with, and declared effective by, the
Securities and Exchange Commission.

The offering will be made only by means of a prospectus, copies of which may be obtained from
Jefferies LLC, Equity Syndicate Prospectus Department, by email at
Prospectus_Department@Jefferies.com, by phone at 877-547-6340 or by mail at 520 Madison
Avenue, 2nd Floor, New York, NY 10022 or Barclays Capital Inc., c/o Broadridge Financial Solutions,
by email at Barclaysprospectus@broadridge.com, by phone at 888-603-5847 or by mail at 1155 Long
Island Avenue, Edgewood, NY 11717.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there
be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would
be unlawful prior to registration or qualification under the securities laws of any such state or
jurisdiction.
Fuente: endovascular.es

endovasculares.es